Novo Nordisk
NVO
#21
Rank
$463.97 B
Marketcap
$102.21
Share price
-2.95%
Change (1 day)
3.03%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of September 2024 : $8.53 Billion USD

According to Novo Nordisk's latest financial reports the company's total debt is $8.53 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$3.99 B7.72%
2022-12-31$3.71 B-8.47%
2021-12-31$4.05 B136.98%
2020-12-31$1.71 B154.68%
2019-12-31$0.67 B751.86%
2018-12-31$78.9 M-71.11%
2017-12-31$0.27 B742.26%
2016-12-31$32.42 M-79.38%
2015-12-31$0.15 B33.71%
2014-12-31$0.11 B195.43%
2013-12-31$39.8 M-55.1%
2012-12-31$88.65 M-40.34%
2011-12-31$0.14 B-62.56%
2010-12-31$0.39 B48.44%
2009-12-31$0.26 B-38.67%
2008-12-31$0.43 B63.14%
2007-12-31$0.26 B-0.48%
2006-12-31$0.26 B-37%
2005-12-31$0.42 B37.18%
2004-12-31$0.31 B6.04%
2003-12-31$0.29 B46.9%
2002-12-31$0.19 B-17.79%
2001-12-31$0.24 B-4.37%
2000-12-31$0.25 B-11.92%
1999-12-31$0.28 B-27.35%
1998-12-31$0.39 B-11.13%
1997-12-31$0.44 B35.06%
1996-12-31$0.33 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
$66.61 B 680.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.11 B 264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.40 B 502.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.46 B 198.32%๐Ÿ‡ซ๐Ÿ‡ท France